Background illustration for clinical trials search

Paid Clinical Trials Montreal

Discover 1,169 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Patency-Coronary Trial

for
Complications Due to Coronary Artery Bypass Graft,
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT01414049

Recruiting

Role of Lung Ultrasound and Pulsed-wave Doppler in Lung Consolidations in Mechanically Ventilated Patients

for
Atelectasis, Pneumonia
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT02100449

Recruiting

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

for
Community-acquired Pneumonia
Location: Montreal, Sherbrooke, Ottawa, Quebec, Portland ME,
Sponsor: University of Manitoba

Sex: All

Age: 18+

Code: NCT05848713

Phase 3, Recruiting

A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies

for
Cancer
Location: Montreal, Ottawa, Toronto, Hamilton, Saint John,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT03847649

Phase 2, Recruiting

Photodynamic Therapy for the Treatment of Chronic Rhinosinusitis

for
Chronic Sinusitis
Location: Montreal
Sponsor: Ondine Biomedical Inc.

Sex: All

Age: 18+

Code: NCT01854619

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

for
Refractory Angina
Location: Montreal, Ottawa, Quebec, Springfield MA, Boston MA,
Sponsor: Shockwave Medical, Inc.

Sex: All

Age: 18+

Code: NCT05102019

Recruiting

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

for
Advanced Solid Tumor
Location: Montreal, Boston MA, Toronto, Pittsburgh PA,
Sponsor: Senhwa Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04890613

Phase 1, Recruiting

Adaptive RadioTherapy for OroPharynx Cancer

for
Oropharynx Cancer, Radiotherapy; Complications,
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT04901234

Phase 2, Recruiting

Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease

for
Lung Cancer, Interstitial Lung Disease
Location: Montreal, Saint John, London, Vancouver
Sponsor: David Palma

Sex: All

Age: 18+

Code: NCT05986318

Phase 2, Recruiting

Dietary Intervention for NSCLC Patients Treated With ICI

for
Non Small Cell Lung Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT05805319

Recruiting

Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's Disease

for
Parkinson Disease, Healthy, Parkinsonian Syndromes
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 50 - 70+

Code: NCT06161636

Recruiting

A New Ultrasonographic Tool to Assess Pulmonary Strain in the ICU

for
Mechanical Ventilation Complication,
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT03405779

Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

for
Metastatic Castration-Resistant Prostate Cancer
Location: Montreal, Chicoutimi, Oshawa, The Bronx NY, Halifax,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT06629779

Phase 3, Recruiting

Modulation of THC Effects by CBD: a Dose-ranging Study

for
Cannabis, THC
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 21 - 49

Code: NCT06099379

Phase 1, Phase 2, Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for
Low Grade Serous Ovarian Cancer
Location: Montreal, New Haven CT, Toronto, New York NY,
Sponsor: Verastem, Inc.

Sex: Female

Age: 18+

Code: NCT06072781

Phase 3, Recruiting

Early Detection of Liver Cancer by QUS

for
Hepatocellular Carcinoma, Liver Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT06345508

Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

for
High-grade Serous Ovarian Carcinoma (HGSOC),
Location: Montreal, Toronto, Hackensack NJ, Vancouver,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06476808

Phase 1, Recruiting

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Montreal, New Haven CT, Cheektowaga NY, Toronto,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06545955

Phase 3, Recruiting

Pilot Physiological Evaluation of an Investigational Mask with Expiratory Washout.

for
Acute Hypercapnic Respiratory Failure,
Location: Montreal, Quebec City
Sponsor: Fisher and Paykel Healthcare

Sex: All

Age: 18+

Code: NCT06007495

Recruiting

First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Advanced Metastatic Castration-resistant Prostate Cancer,
Location: Montreal, Sherbrooke, Toronto, Hamilton, Vancouver
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06217822

Phase 1, Recruiting